# University of Pisa / Azienda Ospedaliero-Universitaria Pisana

Source: https://onco.cc/institutions/university-of-pisa/  
OnCo record `university-of-pisa` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Italian university and hospital whose endocrinology department, under Rossella Elisei, is one of Europe's largest thyroid cancer centres and led the EXAM trial of cabozantinib.

## Summary

The University of Pisa and its hospital, the Azienda Ospedaliero-Universitaria Pisana, run one of Europe's largest thyroid disease units. The Endocrinology Unit's thyroid cancer group, led by Rossella Elisei, coordinated EXAM, the phase 3 trial reported in the Journal of Clinical Oncology in 2013 in which cabozantinib lengthened progression-free survival in progressive medullary thyroid cancer, and studies the prognostic value of RET mutations and calcitonin doubling time.

## Fields

- Kind: Institution
- Last checked: 2026-09-18
- Also known as: Università di Pisa; AOUP; Pisa University Hospital
- City: Pisa, IT
- Type: university
- Website: https://www.unipi.it

## Sources

- Università di Pisa: https://www.unipi.it

## Connected records

- cancers: [Medullary thyroid cancer](https://onco.cc/cancers/medullary-thyroid-cancer/), [Thyroid cancer](https://onco.cc/cancers/thyroid/)
- people: [Rossella Elisei](https://onco.cc/people/rossella-elisei/)

---
JSON: https://onco.cc/api/v1/entities/university-of-pisa.json